SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
LiveWire Ergogenics, Inc. (LVVV) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 19/100 with 0/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — LVVV
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio96.07
EV/EBITDA0.0
Per Share Data
EPS (TTM)$0.00
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2016 |
$0.00 |
$9.07K |
$-78.28K |
-863% |
| 2017 |
$0.00 |
$0.00 |
$-1.2M |
- |
| 2018 |
$-0.01 |
$35.71K |
$-11.59M |
-32465.2% |
| 2019 |
$0.00 |
$344.23K |
$-1.78M |
-515.9% |
| 2020 |
$0.00 |
$580.32K |
$-1.6M |
-275.9% |
| 2021 |
$0.00 |
$851.2K |
$-3.43M |
-403.2% |
| 2022 |
$0.00 |
$1.94M |
$684.12K |
35.3% |
| 2023 |
$0.00 |
$1.63M |
$921.58K |
56.4% |
| 2024 |
$0.00 |
$304.12K |
$78.73K |
25.9% |
| 2025 |
$0.00 |
$7.84K |
$-4.78M |
-61057.3% |
